{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:07:54Z","timestamp":1778519274491,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 82DZL004A1"],"award-info":[{"award-number":["FKZ 82DZL004A1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["183923"],"award-info":[{"award-number":["183923"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"Universit\u00e4t Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV 260 416"],"award-info":[{"award-number":["SVV 260 416"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejpb.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T02:17:52Z","timestamp":1591409872000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Physicochemical and biopharmaceutical characterization of novel Matrix-Liposomes"],"prefix":"10.1016","volume":"153","author":[{"given":"Michael","family":"Binnefeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Balzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Skalick\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Witzigmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ulrich","family":"Kauczor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna J.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.06.001_b0005","doi-asserted-by":"crossref","first-page":"238-IN27","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2017.07.001","article-title":"Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble\/poorly permeable drug delivery","volume":"68","author":"Teixeira","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejpb.2020.06.001_b0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ejpb.2020.06.001_b0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/0929867324666171009120154","article-title":"Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery","volume":"25","author":"Carita","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2020.06.001_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.03.022","article-title":"Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine-N-oxide for the treatment of solid tumors","volume":"253","author":"Shah","year":"2017","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/mmy\/myv111","article-title":"Comparison between liposomal formulations of amphotericin B","volume":"54","author":"Adler-Moore","year":"2016","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/089426802320282257","article-title":"Drug Absorption by the Respiratory Mucosa: Cell Culture Models and Particulate Drug Carriers \/\/ Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers","volume":"15","author":"Ehrhardt","year":"2002","journal-title":"J. Aerosol Med. Off. J. Int. Soc. Aerosols Med."},{"key":"10.1016\/j.ejpb.2020.06.001_b0040","first-page":"367","article-title":"In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer","volume":"29","author":"Anabousi","year":"2006","journal-title":"Eur. J. Pharmaceutical Sci. Off. J. Eur. Federation Pharmaceutical Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejps.2017.07.013","article-title":"Oral delivery of vancomycin by tetraether lipid liposomes","volume":"108","author":"Uhl","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0050","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-010-0130-x","article-title":"Phospholipids and lipid-based formulations in oral drug delivery","volume":"27","author":"Fricker","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.001_b0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1146\/annurev.anchem.1.031207.112747","article-title":"Liposomes: technologies and analytical applications","volume":"1","author":"Jesorka","year":"2008","journal-title":"Ann. Rev. Anal. Chem. (Palo Alto, Calif.)"},{"key":"10.1016\/j.ejpb.2020.06.001_b0060","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1517\/17425247.2012.735658","article-title":"Liposomal delivery of proteins and peptides","volume":"9","author":"Swaminathan","year":"2012","journal-title":"Expert Opinion Drug Deliv."},{"key":"10.1016\/j.ejpb.2020.06.001_b0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2020.06.001_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051161","article-title":"Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems","volume":"25","author":"Perry","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ejpb.2020.06.001_b0075","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jps.24215","article-title":"Improved Oral Bioavailability of Human Growth Hormone by a Combination of Liposomes Containing Bio-Enhancers and Tetraether Lipids and Omeprazole","volume":"103","author":"Parmentier","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0080","first-page":"167","article-title":"Biotinylated liposomes as potential carriers for the oral delivery of insulin, Nanomedicine: Nanotechnology","volume":"10","author":"Zhang","year":"2014","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.ejpb.2020.06.001_b0085","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.1818924116","article-title":"Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels","volume":"116","author":"Yu","year":"2019","journal-title":"Proc. Nat. Acad Sci. U S A"},{"key":"10.1016\/j.ejpb.2020.06.001_b0090","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jconrel.2013.10.011","article-title":"Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats","volume":"172","author":"Gradauer","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.06.001_b0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801123","article-title":"Protein Corona Liposomes Achieve Efficient Oral Insulin Delivery by Overcoming Mucus and Epithelial Barriers","volume":"8","author":"Wang","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejpb.2020.06.001_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5173(91)90287-X","article-title":"An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop","volume":"70","author":"Lehr","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jps.2600740903","article-title":"Liposome-collagen gel matrix: a novel sustained drug delivery system","volume":"74","author":"Weiner","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ejlt.201300409","article-title":"Matrix liposomes: A solid liposomal formulation for oral administration","volume":"116","author":"Pantze","year":"2014","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2007.09.010","article-title":"Dual asymmetric centrifugation (DAC)\u2013a new technique for liposome preparation","volume":"125","author":"Massing","year":"2008","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0125","doi-asserted-by":"crossref","unstructured":"U. Massing, S.G. Ingebrigtsen, Hols\u00e6ter, Nata\u0161a \u0160kalko-Basnet and Ann Mari, N. \u0160kalko-Basnet, A.M. Hols\u00e6ter, Dual Centrifugation - A Novel \u201cin-vial\u201d Liposome Processing Technique -, IntechOpen, 2017, https:\/\/www.intechopen.com\/citation-pdf-url\/55431.","DOI":"10.5772\/intechopen.68523"},{"key":"10.1016\/j.ejpb.2020.06.001_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2017.07.047","article-title":"Dual centrifugation \u2013 A new technique for nanomilling of poorly soluble drugs and formulation screening by an DoE-approach","volume":"530","author":"Hagedorn","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1567201813666160115125756","article-title":"Potential of Liposomes for Enhancement of Oral Drug Absorption","volume":"14","author":"Daeihamed","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2020.06.001_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"V. Pr\u00e9at, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"Des Rieux","year":"2006","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201704245","article-title":"Liposomal Treatment of Cancer Cells Modulates Uptake Pathway of Polymeric Nanoparticles by Altering Membrane Stiffness","volume":"14","author":"Xiang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2020.06.001_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2016.08.055","article-title":"The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison","volume":"108","author":"Weinheimer","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nano.2013.06.013","article-title":"Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition","volume":"10","author":"Kopecka","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2020.06.001_b0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpb.2010.11.009","article-title":"Nanoparticles attenuate P-glycoprotein\/MDR1 function in A549 human alveolar epithelial cells","volume":"77","author":"Salomon","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biocel.2004.11.004","article-title":"Breast cancer resistance protein (BCRP\/ABCG2)","volume":"37","author":"Staud","year":"2005","journal-title":"Int. J. Biochem. & Cell Biol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0170","first-page":"1","article-title":"Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation, European journal of pharmaceutical sciences official journal of the European Federation for","volume":"77","author":"Singh","year":"2015","journal-title":"Pharmaceutical Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2004.09.002","article-title":"Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes","volume":"23","author":"Lacombe","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the Breast Cancer Resistance Protein (BCRP\/ABCG2) in Drug Transport\u2014an Update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.06.001_b0185","first-page":"269","article-title":"Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells","volume":"29","author":"Englund","year":"2006","journal-title":"Eur. J. Pharmaceutical Sci. Off. J. Eur. Federation Pharmaceutical Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/hsz-2016-0259","article-title":"Expression, regulation and function of intestinal drug transporters: an update","volume":"398","author":"M\u00fcller","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.06.001_b0195","doi-asserted-by":"crossref","first-page":"74320","DOI":"10.1039\/C5RA13967H","article-title":"Formation of lipid and polymer based gold nanohybrids using a nanoreactor approach","volume":"5","author":"Witzigmann","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2020.06.001_b0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2017.08.023","article-title":"Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo","volume":"264","author":"Sieber","year":"2017","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0032-1328090","article-title":"Alkamides from Echinacea angustifolia Interact with P-glycoprotein of primary brain capillary endothelial cells isolated from porcine brain blood vessels","volume":"79","author":"Mahringer","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.ejpb.2020.06.001_b0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2016.03.063","article-title":"Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs","volume":"505","author":"Sj\u00f6gren","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12031-007-0006-7","article-title":"Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR","volume":"32","author":"Tanic","year":"2007","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.ejpb.2020.06.001_b0220","first-page":"11","article-title":"Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats","author":"Karimian Pour","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2020.06.001_b0225","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1515\/hsz-2018-0425","article-title":"Aryl hydrocarbon receptor ligands increase ABC transporter activity and protein expression in killifish (Fundulus heteroclitus) renal proximal tubules","volume":"400","author":"Mahringer","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.06.001_b0230","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejpb.2020.06.001_b0235","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.xphs.2016.01.020","article-title":"Effects of Polyoxyethylene Alkyl Ethers on the Intestinal Transport and Absorption of Rhodamine 123: A P-glycoprotein Substrate by In Vitro and In Vivo Studies","volume":"105","author":"Zhao","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.001_b0240","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST\u00a9) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejpb.2020.06.001_b0245","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.bpj.2010.01.012","article-title":"Characterization of particle translocation through mucin hydrogels","volume":"98","author":"Lieleg","year":"2010","journal-title":"Biophys. J ."},{"key":"10.1016\/j.ejpb.2020.06.001_b0250","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jphp.12074","article-title":"Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration","volume":"65","author":"Zhu","year":"2013","journal-title":"J. Pharmacy Pharmacol."},{"issue":"65","key":"10.1016\/j.ejpb.2020.06.001_b0255","first-page":"1340","article-title":"Intestinal drug transporters: An overview","volume":"2013","author":"Estudante","year":"2013","journal-title":"EDITOR'S COLLECTION"},{"key":"10.1016\/j.ejpb.2020.06.001_b0260","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug Metabol. Disposition: Biol. Fate Chem."},{"key":"10.1016\/j.ejpb.2020.06.001_b0265","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00228-012-1417-0","article-title":"Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms","volume":"69","author":"Schiele","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejpb.2020.06.001_b0275","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11164-013-1338-2","article-title":"Advances and new technologies applied in controlled drug delivery system","volume":"41","author":"Bassyouni","year":"2015","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejpb.2020.06.001_b0280","first-page":"163","article-title":"Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications, 3","volume":"10","author":"Khan","year":"2020","journal-title":"Biotech"},{"key":"10.1016\/j.ejpb.2020.06.001_b0285","unstructured":"J. Parmentier, S. Pantze, G. Fricker, Matrix stabilized liposomes, WO2015188946 (2015)."},{"key":"10.1016\/j.ejpb.2020.06.001_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.12.030","article-title":"Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: State of the art review","volume":"557","author":"Breitsamer","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0295","unstructured":"S. Pantze, Liposomes as a solid dosage form and for the oral delivery of vancomycin: presented by Silvia Pantze. Dissertation, Heidelberg, 2016."},{"key":"10.1016\/j.ejpb.2020.06.001_b0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2004.07.045","article-title":"The effects of lyophilization on the stability of liposomes containing 5-FU","volume":"291","author":"Glavas-Dodov","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.001_b0305","first-page":"87","article-title":"The influence of bile salts on the response of liposomes to ultrasound","volume":"26","author":"Mujoo","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2020.06.001_b0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Laboratory Automation"},{"key":"10.1016\/j.ejpb.2020.06.001_b0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/10253890.2016.1154527","article-title":"Subacute stress and chronic stress interact to decrease intestinal barrier function in rats","volume":"19","author":"Lauffer","year":"2016","journal-title":"Stress (Amsterdam, Netherlands)"},{"key":"10.1016\/j.ejpb.2020.06.001_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/nu11050979","article-title":"Grape-Seed Proanthocyanidins are Able to Reverse Intestinal Dysfunction and Metabolic Endotoxemia Induced by a Cafeteria Diet in Wistar Rats","volume":"11","author":"Gonz\u00e1lez-Quilen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejpb.2020.06.001_b0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejpb.2020.06.001_b0330","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00046.2013","article-title":"Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches","volume":"305","author":"Ermund","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/aja.1001270104","article-title":"Factors influencing villus size in the small intestine of adult rats as revealed by transposition of intestinal segments","volume":"127","author":"Altmann","year":"1970","journal-title":"Am. J. Anatomy"},{"key":"10.1016\/j.ejpb.2020.06.001_b0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","article-title":"The influence of small intestinal mucus structure on particle transport ex vivo, Colloids and surfaces","volume":"135","author":"Bajka","year":"2015","journal-title":"B, Biointerfaces"},{"key":"10.1016\/j.ejpb.2020.06.001_b0345","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0033-1335042","article-title":"Mukosaschutz durch Phosphatidylcholin als neues therapeutisches Prinzip bei der Colitis ulcerosa","volume":"51","author":"Stremmel","year":"2013","journal-title":"Z. Gastroenterol."},{"issue":"Suppl 3","key":"10.1016\/j.ejpb.2020.06.001_b0350","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000342729","article-title":"Mucosal protection by phosphatidylcholine","volume":"30","author":"Stremmel","year":"2012","journal-title":"Digestive Diseases (Basel, Switzerland)"},{"key":"10.1016\/j.ejpb.2020.06.001_b0355","first-page":"983","article-title":"Phosphatidylcholine as a constituent in the colonic mucosal barrier\u2013physiological and clinical relevance","volume":"2010","author":"Ehehalt","year":"1801","journal-title":"BBA"},{"key":"10.1016\/j.ejpb.2020.06.001_b0360","first-page":"195","article-title":"Current concepts in intestinal peptide absorption","volume":"2","author":"Fricker","year":"1996","journal-title":"J. Peptide Sci. Off. Publ. Eur. Peptide Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-0773.2002.900103.x","article-title":"Relevance of multidrug resistance proteins for intestinal drug absorption in vitro and in vivo","volume":"90","author":"Fricker","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejpb.2020.06.001_b0370","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ejpb.2020.06.001_b0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1248\/bpb.b17-00725","article-title":"Advances in Studies of P-Glycoprotein and Its Expression Regulators","volume":"41","author":"Yano","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.06.001_b0380","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metabol. Disposition: Biol. Fate Chem."},{"key":"10.1016\/j.ejpb.2020.06.001_b0385","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J. Controlled Release Off. J. Controlled Release Soc."},{"key":"10.1016\/j.ejpb.2020.06.001_b0390","first-page":"1211","article-title":"Inhibitory effect of phospholipids on P-glycoprotein: cellular studies in Caco-2, MDCKII mdr1 and MDCKII wildtype cells and P-gp ATPase activity measurements","volume":"2012","author":"Simon","year":"1821","journal-title":"BBA"},{"key":"10.1016\/j.ejpb.2020.06.001_b0395","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1389200211314060001","article-title":"Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier","volume":"14","author":"Pinz\u00f3n-Daza","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2020.06.001_b0400","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2017.01.035","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-gp\/ABCB1) transport afatinib and restrict its oral availability and brain accumulation","volume":"120","author":"van Hoppe","year":"2017","journal-title":"Pharmacol. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:08:10Z","timestamp":1778515690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120301600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":80,"alternative-id":["S0939641120301600"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical and biopharmaceutical characterization of novel Matrix-Liposomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}